Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Phase 3, Double-blind, Placebo-controlled Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma(RENAVIV)

Trial Profile

A Randomized, Phase 3, Double-blind, Placebo-controlled Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma(RENAVIV)

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abexinostat (Primary) ; Pazopanib (Primary)
  • Indications Renal cell carcinoma
  • Focus Registrational; Therapeutic Use
  • Acronyms RENAVIV
  • Sponsors Xynomic Pharmaceuticals
  • Most Recent Events

    • 08 Jul 2019 Status changed from recruiting to active, no longer recruiting.
    • 20 Mar 2019 According to a Xynomic Pharmaceuticals media release, the company will sponsor an investigator meeting to bring together European Union physicians, care providers and clinical research coordinators on 22 Mar 2019.
    • 16 Mar 2019 According to a Xynomic media release, the authorities of China, Spain and Poland have approved to conduct this study. The company plans to initiate this trial in China, Spain, Poland and additional European countries in the first half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top